Emkay Global Financial Services Limited has informed the Exchanges about receipt of Trading approval letter for 2,78,300 Equity Shares having face value of Rs. 10/- each allotted at the price of Rs. 239.50/- (including premium of Rs. 229.50/-) per equity share pursuant to conversion of warrants issued on a preferential basis to the Promoter of the Company in terms of Chapter V of SEBI (ICDR) Regulations, 2018.
EMKAY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Emkay Global Financial Services has received trading approval from NSE and BSE for 2,78,300 equity shares (face value Rs. 10) allotted to the Promoter at Rs. 239.50 per share (including a premium of Rs. 229.50), pursuant to conversion of warrants issued on a preferential basis under SEBI ICDR Regulations. The new shares will start trading on the exchanges from March 25, 2026. As a result, the total listed equity capital of the company has increased to Rs. 26.19 crore, comprising 2,61,89,063 fully paid-up shares. These newly allotted shares are subject to a lock-in period until September 25, 2027, meaning the Promoter cannot sell them for about 18 months.
Existing shareholders face mild equity dilution, but the Promoter is increasing its stake, signaling confidence in the company. The 18-month lock-in means no immediate selling pressure from these new shares, which is a positive for the stock price.